| Mangalam Drugs and Organics Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532637 |
NSE Symbol : MANGALAM |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE584F01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 80.50 |
Market Cap(₹Cr) : 47.50 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 67.29 | 58.38 | 49.26 | 57.21 | 72.78 | 88.55 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 67.29 | 58.38 | 49.26 | 57.21 | 72.78 | 88.55 |
| Other Operating Income | 0.00 | 0.00 | 0.28 | 0.14 | 0.00 | 0.16 |
| Other Income | 0.09 | 0.22 | 0.03 | 0.00 | 0.47 | 0.13 |
| Total Income | 67.38 | 58.60 | 49.57 | 57.35 | 73.25 | 88.84 |
| Total Expenditure | 72.64 | 59.96 | 52.38 | 61.85 | 62.88 | 79.94 |
| PBIDT | -5.27 | -1.36 | -2.81 | -4.50 | 10.37 | 8.90 |
| Interest | 3.08 | 4.05 | 5.03 | 4.04 | 4.03 | 3.49 |
| PBDT | -8.35 | -5.41 | -7.83 | -8.55 | 6.34 | 5.41 |
| Depreciation | 4.56 | 4.37 | 4.53 | 4.38 | 4.61 | 3.93 |
| Tax | 0.00 | 0.00 | 0.29 | 0.00 | 0.07 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.15 | 0.00 | -5.41 | 0.80 | 1.50 | 0.08 |
| Reported Profit After Tax | -13.06 | -9.78 | -7.25 | -13.73 | 0.15 | 1.40 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -13.06 | -9.78 | -7.25 | -13.73 | 0.15 | 1.40 |
| EPS (Unit Curr.) | -8.25 | -6.18 | -4.58 | -8.67 | 0.10 | 0.89 |
| EPS (Adj) (Unit Curr.) | -8.25 | -6.18 | -4.58 | -8.67 | 0.10 | 0.89 |
| Calculated EPS (Unit Curr.) | -8.25 | -6.18 | -4.58 | -8.67 | 0.10 | 0.89 |
| Calculated EPS (Adj) (Unit Curr.) | -8.25 | -6.18 | -4.58 | -8.67 | 0.10 | 0.89 |
| Calculated EPS (Ann.) (Unit Curr.) | -33.01 | -24.71 | -18.31 | -34.69 | 0.38 | 3.54 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -33.01 | -24.71 | -18.31 | -34.69 | 0.38 | 3.54 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -7.83 | -2.33 | -5.70 | -7.87 | 14.25 | 10.05 |
| PBDTM(%) | -12.41 | -9.27 | -15.90 | -14.94 | 8.71 | 6.11 |
| PATM(%) | -19.41 | -16.75 | -14.72 | -24.00 | 0.21 | 1.58 |
